Open label safety and efficacy pilot to study mitigation of equine recurrent uveitis through topical suppressor of cytokine signaling-1 mimetic peptide

Equine recurrent uveitis (ERU) is a painful and debilitating autoimmune disease and represents the only spontaneous model of human recurrent uveitis (RU). Despite the efficacy of existing treatments, RU remains a leading cause of visual handicap in horses and humans. Cytokines, which utilize Janus k...

Full description

Saved in:
Bibliographic Details
Published inScientific reports Vol. 12; no. 1; pp. 7177 - 11
Main Authors Plummer, Caryn E., Polk, Timothy, Sharma, Jatin, Bae, Sanghyo Sarah, Barr, Olivia, Jones, Amari, Kitchen, Holly, Wilhelmy, Michelle, Devin, K., Clay Smith, W., Kolaczkowski, Bryan D., Larkin, Joseph
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 03.05.2022
Nature Publishing Group
Nature Portfolio
Subjects
631/250
631/250/127
631/250/24
631/250/249
631/250/251
631/250/2520
631/250/256
631/250/38
631/250/516
692/699/3161
692/699/3161/3177
Animals
Autoimmune Diseases
Bioinformatics
Blindness
Chronic Disease
Cytokines
Cytokines - metabolism
Horse Diseases - drug therapy
Horses
Humanities and Social Sciences
Inflammation
Janus kinase
Janus kinase 2
multidisciplinary
Patients
Peptides
Peptides - metabolism
Pilot Projects
Rodents
Science
Science (multidisciplinary)
SOCS-1 protein
Suppressor of Cytokine Signaling 1 Protein - metabolism
Suppressor of Cytokine Signaling Proteins - metabolism
Uveitis
Uveitis - drug therapy
Uveitis - veterinary
Online AccessGet full text
ISSN2045-2322
2045-2322
DOI10.1038/s41598-022-11338-x

Cover

Abstract Equine recurrent uveitis (ERU) is a painful and debilitating autoimmune disease and represents the only spontaneous model of human recurrent uveitis (RU). Despite the efficacy of existing treatments, RU remains a leading cause of visual handicap in horses and humans. Cytokines, which utilize Janus kinase 2 (Jak2) for signaling, drive the inflammatory processes in ERU that promote blindness. Notably, suppressor of cytokine signaling 1 (SOCS1), which naturally limits the activation of Jak2 through binding interactions, is often deficient in autoimmune disease patients. Significantly, we previously showed that topical administration of a SOCS1 peptide mimic (SOCS1-KIR) mitigated induced rodent uveitis. In this pilot study, we test the potential to translate the therapeutic efficacy observed in experimental rodent uveitis to equine patient disease. Through bioinformatics and peptide binding assays we demonstrate putative binding of the SOCS1-KIR peptide to equine Jak2. We also show that topical, or intravitreal injection of SOCS1-KIR was well tolerated within the equine eye through physical and ophthalmic examinations. Finally, we show that topical SOCS1-KIR administration was associated with significant clinical ERU improvement. Together, these results provide a scientific rationale, and supporting experimental evidence for the therapeutic use of a SOCS1 mimetic peptide in RU.
AbstractList Equine recurrent uveitis (ERU) is a painful and debilitating autoimmune disease and represents the only spontaneous model of human recurrent uveitis (RU). Despite the efficacy of existing treatments, RU remains a leading cause of visual handicap in horses and humans. Cytokines, which utilize Janus kinase 2 (Jak2) for signaling, drive the inflammatory processes in ERU that promote blindness. Notably, suppressor of cytokine signaling 1 (SOCS1), which naturally limits the activation of Jak2 through binding interactions, is often deficient in autoimmune disease patients. Significantly, we previously showed that topical administration of a SOCS1 peptide mimic (SOCS1-KIR) mitigated induced rodent uveitis. In this pilot study, we test the potential to translate the therapeutic efficacy observed in experimental rodent uveitis to equine patient disease. Through bioinformatics and peptide binding assays we demonstrate putative binding of the SOCS1-KIR peptide to equine Jak2. We also show that topical, or intravitreal injection of SOCS1-KIR was well tolerated within the equine eye through physical and ophthalmic examinations. Finally, we show that topical SOCS1-KIR administration was associated with significant clinical ERU improvement. Together, these results provide a scientific rationale, and supporting experimental evidence for the therapeutic use of a SOCS1 mimetic peptide in RU.
Equine recurrent uveitis (ERU) is a painful and debilitating autoimmune disease and represents the only spontaneous model of human recurrent uveitis (RU). Despite the efficacy of existing treatments, RU remains a leading cause of visual handicap in horses and humans. Cytokines, which utilize Janus kinase 2 (Jak2) for signaling, drive the inflammatory processes in ERU that promote blindness. Notably, suppressor of cytokine signaling 1 (SOCS1), which naturally limits the activation of Jak2 through binding interactions, is often deficient in autoimmune disease patients. Significantly, we previously showed that topical administration of a SOCS1 peptide mimic (SOCS1-KIR) mitigated induced rodent uveitis. In this pilot study, we test the potential to translate the therapeutic efficacy observed in experimental rodent uveitis to equine patient disease. Through bioinformatics and peptide binding assays we demonstrate putative binding of the SOCS1-KIR peptide to equine Jak2. We also show that topical, or intravitreal injection of SOCS1-KIR was well tolerated within the equine eye through physical and ophthalmic examinations. Finally, we show that topical SOCS1-KIR administration was associated with significant clinical ERU improvement. Together, these results provide a scientific rationale, and supporting experimental evidence for the therapeutic use of a SOCS1 mimetic peptide in RU.
Equine recurrent uveitis (ERU) is a painful and debilitating autoimmune disease and represents the only spontaneous model of human recurrent uveitis (RU). Despite the efficacy of existing treatments, RU remains a leading cause of visual handicap in horses and humans. Cytokines, which utilize Janus kinase 2 (Jak2) for signaling, drive the inflammatory processes in ERU that promote blindness. Notably, suppressor of cytokine signaling 1 (SOCS1), which naturally limits the activation of Jak2 through binding interactions, is often deficient in autoimmune disease patients. Significantly, we previously showed that topical administration of a SOCS1 peptide mimic (SOCS1-KIR) mitigated induced rodent uveitis. In this pilot study, we test the potential to translate the therapeutic efficacy observed in experimental rodent uveitis to equine patient disease. Through bioinformatics and peptide binding assays we demonstrate putative binding of the SOCS1-KIR peptide to equine Jak2. We also show that topical, or intravitreal injection of SOCS1-KIR was well tolerated within the equine eye through physical and ophthalmic examinations. Finally, we show that topical SOCS1-KIR administration was associated with significant clinical ERU improvement. Together, these results provide a scientific rationale, and supporting experimental evidence for the therapeutic use of a SOCS1 mimetic peptide in RU.Equine recurrent uveitis (ERU) is a painful and debilitating autoimmune disease and represents the only spontaneous model of human recurrent uveitis (RU). Despite the efficacy of existing treatments, RU remains a leading cause of visual handicap in horses and humans. Cytokines, which utilize Janus kinase 2 (Jak2) for signaling, drive the inflammatory processes in ERU that promote blindness. Notably, suppressor of cytokine signaling 1 (SOCS1), which naturally limits the activation of Jak2 through binding interactions, is often deficient in autoimmune disease patients. Significantly, we previously showed that topical administration of a SOCS1 peptide mimic (SOCS1-KIR) mitigated induced rodent uveitis. In this pilot study, we test the potential to translate the therapeutic efficacy observed in experimental rodent uveitis to equine patient disease. Through bioinformatics and peptide binding assays we demonstrate putative binding of the SOCS1-KIR peptide to equine Jak2. We also show that topical, or intravitreal injection of SOCS1-KIR was well tolerated within the equine eye through physical and ophthalmic examinations. Finally, we show that topical SOCS1-KIR administration was associated with significant clinical ERU improvement. Together, these results provide a scientific rationale, and supporting experimental evidence for the therapeutic use of a SOCS1 mimetic peptide in RU.
Abstract Equine recurrent uveitis (ERU) is a painful and debilitating autoimmune disease and represents the only spontaneous model of human recurrent uveitis (RU). Despite the efficacy of existing treatments, RU remains a leading cause of visual handicap in horses and humans. Cytokines, which utilize Janus kinase 2 (Jak2) for signaling, drive the inflammatory processes in ERU that promote blindness. Notably, suppressor of cytokine signaling 1 (SOCS1), which naturally limits the activation of Jak2 through binding interactions, is often deficient in autoimmune disease patients. Significantly, we previously showed that topical administration of a SOCS1 peptide mimic (SOCS1-KIR) mitigated induced rodent uveitis. In this pilot study, we test the potential to translate the therapeutic efficacy observed in experimental rodent uveitis to equine patient disease. Through bioinformatics and peptide binding assays we demonstrate putative binding of the SOCS1-KIR peptide to equine Jak2. We also show that topical, or intravitreal injection of SOCS1-KIR was well tolerated within the equine eye through physical and ophthalmic examinations. Finally, we show that topical SOCS1-KIR administration was associated with significant clinical ERU improvement. Together, these results provide a scientific rationale, and supporting experimental evidence for the therapeutic use of a SOCS1 mimetic peptide in RU.
ArticleNumber 7177
Author Sharma, Jatin
Plummer, Caryn E.
Bae, Sanghyo Sarah
Devin, K.
Kolaczkowski, Bryan D.
Polk, Timothy
Wilhelmy, Michelle
Clay Smith, W.
Barr, Olivia
Jones, Amari
Kitchen, Holly
Larkin, Joseph
Author_xml – sequence: 1
  givenname: Caryn E.
  surname: Plummer
  fullname: Plummer, Caryn E.
  email: plummerc@ufl.edu
  organization: Department of Large and Small Animal Clinical Sciences, College of Veterinary Medicine, Institute of Food and Agricultural Science, University of Florida
– sequence: 2
  givenname: Timothy
  surname: Polk
  fullname: Polk, Timothy
  organization: Department of Microbiology and Cell Science, College of Agricultural and Life Sciences, University of Florida
– sequence: 3
  givenname: Jatin
  surname: Sharma
  fullname: Sharma, Jatin
  organization: Department of Microbiology and Cell Science, College of Agricultural and Life Sciences, University of Florida
– sequence: 4
  givenname: Sanghyo Sarah
  surname: Bae
  fullname: Bae, Sanghyo Sarah
  organization: Department of Microbiology and Cell Science, College of Agricultural and Life Sciences, University of Florida
– sequence: 5
  givenname: Olivia
  surname: Barr
  fullname: Barr, Olivia
  organization: Department of Microbiology and Cell Science, College of Agricultural and Life Sciences, University of Florida
– sequence: 6
  givenname: Amari
  surname: Jones
  fullname: Jones, Amari
  organization: Department of Microbiology and Cell Science, College of Agricultural and Life Sciences, University of Florida
– sequence: 7
  givenname: Holly
  surname: Kitchen
  fullname: Kitchen, Holly
  organization: Department of Large and Small Animal Clinical Sciences, College of Veterinary Medicine, Institute of Food and Agricultural Science, University of Florida
– sequence: 8
  givenname: Michelle
  surname: Wilhelmy
  fullname: Wilhelmy, Michelle
  organization: Department of Large and Small Animal Clinical Sciences, College of Veterinary Medicine, Institute of Food and Agricultural Science, University of Florida
– sequence: 9
  givenname: K.
  surname: Devin
  fullname: Devin, K.
  organization: Department of Large and Small Animal Clinical Sciences, College of Veterinary Medicine, Institute of Food and Agricultural Science, University of Florida
– sequence: 10
  givenname: W.
  surname: Clay Smith
  fullname: Clay Smith, W.
  organization: Department of Ophthalmology Research, College of Medicine, University of Florida
– sequence: 11
  givenname: Bryan D.
  surname: Kolaczkowski
  fullname: Kolaczkowski, Bryan D.
  organization: Department of Microbiology and Cell Science, College of Agricultural and Life Sciences, University of Florida
– sequence: 12
  givenname: Joseph
  surname: Larkin
  fullname: Larkin, Joseph
  email: jlarkin3@ufl.edu
  organization: Department of Microbiology and Cell Science, College of Agricultural and Life Sciences, University of Florida
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35505065$$D View this record in MEDLINE/PubMed
BookMark eNp9ks1u1DAUhS1URMvQF2CBLLFhE_BvEm-QUMVPpUrdwNpynJuMS8ZObafqPAmvi2emlLaLZuMoPufzie95jY588IDQW0o-UsLbT0lQqdqKMFZRynlb3b5AJ4wIWTHO2NGD92N0mtIVKY9kSlD1Ch1zKYkktTxBfy5n8HgyHUw4mQHyFhvfYxgGZ43d4tlNIeMccMpLv8Ubl91osgsehwHD9eI84Ah2iRF8xssNFEHCeR3DMq6Lby6YQl7mOUJKIe5sdpvD750xudGbyfmxooW8gewsnmHOroc36OVgpgSnd-sK_fr29efZj-ri8vv52ZeLykpBcgVcCMs5VXVXN4Jw0QvGiGXCghDMdkqBUryTtrVWyV4AMw1vOq5Iazjlgq_Q-YHbB3Ol5-g2Jm51ME7vP4Q4ahNLrgk0pdLWjMuh5VaojhnGGiI6TljPSFNmsEKfD6x56TbQ23Ij0UyPoI93vFvrMdxoVUZBhSyAD3eAGK4XSFlvXLIwTcZDWJJmtVQ1YW29y_3-ifQqLLHc5l7VqlZy1RTVu4eJ7qP8m38RsIPAxpBShOFeQone9UwfeqZLz_S-Z_q2mNonJuvyvhTlr9z0vJUfrKmc40eI_2M_4_oLtTDpPQ
CitedBy_id crossref_primary_10_3389_fimmu_2023_1271102
crossref_primary_10_1016_j_ejmech_2022_114781
crossref_primary_10_1111_vop_13107
crossref_primary_10_3389_fimmu_2024_1513157
crossref_primary_10_1007_s10753_023_01886_3
crossref_primary_10_1016_j_bcp_2024_116605
crossref_primary_10_3389_fimmu_2024_1406886
Cites_doi 10.1042/BJ20111647
10.1016/S0749-0739(17)30441-8
10.1016/S0165-2427(99)00082-3
10.1074/jbc.M116.746164
10.1002/cpbi.3
10.1016/j.cveq.2004.04.010
10.1016/j.jaut.2015.05.011
10.1016/j.jneuroim.2010.10.018
10.4049/jimmunol.178.8.5058
10.1016/S1471-4892(03)00070-5
10.1093/bioinformatics/btp033
10.1038/s41467-018-04013-1
10.3389/fimmu.2015.00183
10.2147/OPTH.S68595
10.4049/jimmunol.180.9.6070
10.1111/vop.12704
10.1016/j.vetimm.2016.09.008
10.1016/S0022-2836(05)80360-2
10.1111/j.1463-5224.2011.00951.x
10.3389/fimmu.2013.00469
10.4049/jimmunol.1003819
10.4161/jkst.24134
10.1177/030098589803500606
10.1093/nar/gkv1189
10.1167/iovs.16-19787
10.1111/sji.12475
10.1155/2016/2939370
10.1371/journal.pone.0071619
10.3389/fphar.2019.00324
10.1016/j.tvjl.2015.06.017
10.1016/j.jneuroim.2014.05.013
10.1038/s41598-021-86017-4
10.1093/nar/16.22.10881
10.1155/2013/986789
10.3389/fimmu.2020.609855
10.1038/nm1585
10.3389/fimmu.2020.00358
10.1167/iovs.11-7688
10.1093/nar/gkn180
10.1006/bbrc.1998.8077
10.1111/ceo.13511
10.1038/nm.3554
10.1111/j.2042-3306.2010.tb05636.x
10.1016/j.dci.2014.02.009
10.1084/jem.20071258
10.1001/archopht.1994.01090170052021
10.1016/j.ophtha.2003.06.014
10.1101/gr.849004
10.1007/978-1-0716-1036-7_18
ContentType Journal Article
Copyright The Author(s) 2022
2022. The Author(s).
The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2022
– notice: 2022. The Author(s).
– notice: The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88A
88E
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
Q9U
7X8
5PM
DOA
DOI 10.1038/s41598-022-11338-x
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Database
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Science Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

Publicly Available Content Database
MEDLINE - Academic

CrossRef
MEDLINE
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: BENPR
  name: ProQuest Central - New (Subscription)
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2045-2322
EndPage 11
ExternalDocumentID oai_doaj_org_article_115c6235f83c49b2a22704b302d20713
PMC9065145
35505065
10_1038_s41598_022_11338_x
Genre Journal Article
GrantInformation_xml – fundername: Hhmd, LLC
– fundername: University of Florida
– fundername: ;
GroupedDBID 0R~
3V.
4.4
53G
5VS
7X7
88A
88E
88I
8FE
8FH
8FI
8FJ
AAFWJ
AAJSJ
AAKDD
ABDBF
ABUWG
ACGFS
ACSMW
ACUHS
ADBBV
ADRAZ
AENEX
AEUYN
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
DWQXO
EBD
EBLON
EBS
ESX
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
KQ8
LK8
M0L
M1P
M2P
M48
M7P
M~E
NAO
OK1
PIMPY
PQQKQ
PROAC
PSQYO
RNT
RNTTT
RPM
SNYQT
UKHRP
AASML
AAYXX
AFPKN
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7XB
8FK
AARCD
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
Q9U
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c540t-e344c33196b674034d4220c24ce442cb99e993b5c8cc95d4e2a737b3908a31343
IEDL.DBID AAJSJ
ISSN 2045-2322
IngestDate Wed Aug 27 01:32:43 EDT 2025
Thu Aug 21 18:15:06 EDT 2025
Fri Sep 05 06:05:01 EDT 2025
Wed Aug 13 09:29:27 EDT 2025
Wed Feb 19 02:25:23 EST 2025
Tue Jul 01 04:16:20 EDT 2025
Thu Apr 24 22:59:40 EDT 2025
Fri Feb 21 02:40:14 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License 2022. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c540t-e344c33196b674034d4220c24ce442cb99e993b5c8cc95d4e2a737b3908a31343
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.nature.com/articles/s41598-022-11338-x
PMID 35505065
PQID 2658985397
PQPubID 2041939
PageCount 11
ParticipantIDs doaj_primary_oai_doaj_org_article_115c6235f83c49b2a22704b302d20713
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9065145
proquest_miscellaneous_2659602864
proquest_journals_2658985397
pubmed_primary_35505065
crossref_primary_10_1038_s41598_022_11338_x
crossref_citationtrail_10_1038_s41598_022_11338_x
springer_journals_10_1038_s41598_022_11338_x
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-05-03
PublicationDateYYYYMMDD 2022-05-03
PublicationDate_xml – month: 05
  year: 2022
  text: 2022-05-03
  day: 03
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Scientific reports
PublicationTitleAbbrev Sci Rep
PublicationTitleAlternate Sci Rep
PublicationYear 2022
Publisher Nature Publishing Group UK
Nature Publishing Group
Nature Portfolio
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
– name: Nature Portfolio
References Sukka-Ganesh, Larkin (CR20) 2016; 84
Gritz, Wong (CR7) 2004; 111
Collins (CR22) 2011
Gilger (CR9) 1999; 71
Doti (CR41) 2012; 443
Kulbrock, Lehner, Metzger, Ohnesorge, Distl (CR13) 2013; 8
CR32
Sedeño-Monge (CR19) 2014; 273
Yu (CR17) 2011; 52
O’Leary (CR26) 2016; 44
Waiboci (CR39) 2007; 178
Saldinger (CR48) 2020; 23
Jager (CR23) 2011; 232
Skjesol (CR16) 2014; 45
Altschul, Gish, Miller, Myers, Lipman (CR36) 1990; 215
Bonacini (CR45) 2020
McCormick, Gowda, Fang, Heller (CR18) 2016
Ahmed, Larkin, Johnson (CR42) 2015
He (CR49) 2016
Waterhouse, Procter, Martin, Clamp, Barton (CR29) 2009; 25
Liau (CR40) 2018; 9
Regan (CR8) 2012; 15
Dereeper (CR31) 2008
Curto, Messenger, Salmon, Gilger (CR46) 2016; 182
Bedoya, Lam, Lau, Larkin (CR50) 2013; 2013
Liu, Lee, Yu, Egwuagu (CR10) 2008; 180
Gilger (CR4) 2010; 42
He (CR5) 2016; 2016
Gilger, Michau (CR2) 2004; 20
Sharma, Larkin (CR21) 2019
Sharma (CR24) 2021
Degroote, Deeg (CR1) 2021
Kleinwort (CR51) 2016; 57
Amadi-Obi (CR12) 2007; 13
McDonald, Shadduck (CR35) 1977; 4
Green, Larkin, Subramaniam, Szente, Johnson (CR34) 1998; 243
Taravella (CR6) 1994; 112
Luger (CR11) 2008; 205
Crooks, Hon, Chandonia, Brenner (CR30) 2004; 14
Corpet (CR27) 1988; 16
Wang (CR44) 2014; 20
Schwink (CR3) 1992; 8
Malalana, Stylianides, McGowan (CR47) 2015; 206
CR28
Romeike, Brügmann, Drommer (CR52) 1998; 35
He (CR25) 2015; 62
Lin (CR14) 2015
Hassan (CR43) 2019; 47
Egwuagu, Larkin (CR38) 2013; 2
Inagaki-Ohara, Hanada, Yoshimura (CR15) 2003; 3
Webb, Sali (CR33) 2016
Larkin, Ahmed, Wilson, Johnson (CR37) 2013
LD Jager (11338_CR23) 2011; 232
BC Gilger (11338_CR2) 2004; 20
GE Crooks (11338_CR30) 2004; 14
LK Saldinger (11338_CR48) 2020; 23
RL Degroote (11338_CR1) 2021
D Luger (11338_CR11) 2008; 205
X Liu (11338_CR10) 2008; 180
A Skjesol (11338_CR16) 2014; 45
J Sharma (11338_CR21) 2019
EL Collins (11338_CR22) 2011
KJH Kleinwort (11338_CR51) 2016; 57
TP McDonald (11338_CR35) 1977; 4
KL Schwink (11338_CR3) 1992; 8
P Lin (11338_CR14) 2015
K Inagaki-Ohara (11338_CR15) 2003; 3
CE Egwuagu (11338_CR38) 2013; 2
B Sukka-Ganesh (11338_CR20) 2016; 84
BC Gilger (11338_CR9) 1999; 71
M Hassan (11338_CR43) 2019; 47
C He (11338_CR49) 2016
F Malalana (11338_CR47) 2015; 206
C He (11338_CR25) 2015; 62
A Romeike (11338_CR52) 1998; 35
V Sedeño-Monge (11338_CR19) 2014; 273
NPD Liau (11338_CR40) 2018; 9
N Doti (11338_CR41) 2012; 443
A Dereeper (11338_CR31) 2008
MM Green (11338_CR34) 1998; 243
M Bonacini (11338_CR45) 2020
DP Regan (11338_CR8) 2012; 15
A Amadi-Obi (11338_CR12) 2007; 13
E Curto (11338_CR46) 2016; 182
M Kulbrock (11338_CR13) 2013; 8
NA O’Leary (11338_CR26) 2016; 44
SF Altschul (11338_CR36) 1990; 215
DC Gritz (11338_CR7) 2004; 111
11338_CR28
CMI Ahmed (11338_CR42) 2015
F Corpet (11338_CR27) 1988; 16
LW Waiboci (11338_CR39) 2007; 178
C He (11338_CR5) 2016; 2016
C-R Yu (11338_CR17) 2011; 52
J Sharma (11338_CR24) 2021
BC Gilger (11338_CR4) 2010; 42
J Larkin (11338_CR37) 2013
MJ Taravella (11338_CR6) 1994; 112
B Webb (11338_CR33) 2016
R-X Wang (11338_CR44) 2014; 20
SK Bedoya (11338_CR50) 2013; 2013
SM McCormick (11338_CR18) 2016
AM Waterhouse (11338_CR29) 2009; 25
11338_CR32
References_xml – volume: 443
  start-page: 231
  year: 2012
  end-page: 240
  ident: CR41
  article-title: New mimetic peptides of the kinase-inhibitory region (KIR) of SOCS1 through focused peptide libraries
  publication-title: Biochem. J.
  doi: 10.1042/BJ20111647
– volume: 8
  start-page: 557
  year: 1992
  end-page: 574
  ident: CR3
  article-title: Equine uveitis
  publication-title: Vet. Clin. N. Am. Equine Pract.
  doi: 10.1016/S0749-0739(17)30441-8
– volume: 71
  start-page: 17
  year: 1999
  end-page: 28
  ident: CR9
  article-title: Characterization of T-lymphocytes in the anterior uvea of eyes with chronic equine recurrent uveitis
  publication-title: Vet. Immunol. Immunopathol.
  doi: 10.1016/S0165-2427(99)00082-3
– year: 2016
  ident: CR18
  article-title: Suppressor of cytokine signaling (SOCS)1 regulates interleukin-4 (IL-4)-activated insulin receptor substrate (IRS)-2 tyrosine phosphorylation in monocytes and macrophages via the proteasome
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M116.746164
– year: 2016
  ident: CR33
  article-title: Comparative protein structure modeling using MODELLER
  publication-title: Curr. Protocols Bioinform.
  doi: 10.1002/cpbi.3
– volume: 20
  start-page: 417
  year: 2004
  end-page: 427
  ident: CR2
  article-title: Equine recurrent uveitis: New methods of management
  publication-title: Vet. Clin. N. Am. Equine Pract.
  doi: 10.1016/j.cveq.2004.04.010
– volume: 62
  start-page: 31
  year: 2015
  end-page: 38
  ident: CR25
  article-title: Topical administration of a suppressor of cytokine signaling-1 (SOCS1) mimetic peptide inhibits ocular inflammation and mitigates ocular pathology during mouse uveitis
  publication-title: J. Autoimmun.
  doi: 10.1016/j.jaut.2015.05.011
– volume: 232
  start-page: 108
  year: 2011
  end-page: 118
  ident: CR23
  article-title: The kinase inhibitory region of SOCS-1 is sufficient to inhibit T-helper 17 and other immune functions in experimental allergic encephalomyelitis
  publication-title: J. Neuroimmunol.
  doi: 10.1016/j.jneuroim.2010.10.018
– volume: 178
  start-page: 5058
  year: 2007
  end-page: 5068
  ident: CR39
  article-title: Both the suppressor of cytokine signaling 1 (SOCS-1) kinase inhibitory region and SOCS-1 mimetic bind to JAK2 autophosphorylation site: Implications for the development of a SOCS-1 antagonist
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.178.8.5058
– volume: 4
  start-page: 139
  year: 1977
  end-page: 191
  ident: CR35
  article-title: Eye irritation
  publication-title: Mod. Adv. Toxicol.
– volume: 3
  start-page: 435
  year: 2003
  end-page: 442
  ident: CR15
  article-title: Negative regulation of cytokine signaling and inflammatory diseases
  publication-title: Curr. Opin. Pharmacol.
  doi: 10.1016/S1471-4892(03)00070-5
– volume: 25
  start-page: 1189
  year: 2009
  end-page: 1191
  ident: CR29
  article-title: Jalview Version 2-A multiple sequence alignment editor and analysis workbench
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btp033
– volume: 9
  start-page: 1558
  year: 2018
  ident: CR40
  article-title: The molecular basis of JAK/STAT inhibition by SOCS1
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-018-04013-1
– year: 2015
  ident: CR42
  article-title: SOCS1 mimetics and antagonists: A complementary approach to positive and negative regulation of immune function
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2015.00183
– year: 2015
  ident: CR14
  article-title: Targeting interleukin-6 for noninfectious uveitis
  publication-title: Clin. Ophthalmol.
  doi: 10.2147/OPTH.S68595
– volume: 180
  start-page: 6070
  year: 2008
  end-page: 6076
  ident: CR10
  article-title: Loss of STAT3 in CD4 + T cells prevents development of experimental autoimmune diseases
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.180.9.6070
– volume: 23
  start-page: 160
  year: 2020
  end-page: 170
  ident: CR48
  article-title: Horses with equine recurrent uveitis have an activated CD4+ T-cell phenotype that can be modulated by mesenchymal stem cells in vitro
  publication-title: Vet. Ophthalmol.
  doi: 10.1111/vop.12704
– volume: 2016
  start-page: 1
  year: 2016
  end-page: 15
  ident: CR5
  article-title: SOCS1 mimetic peptide suppresses chronic intraocular inflammatory disease (Uveitis)
  publication-title: Mediators Inflamm.
– volume: 182
  start-page: 43
  year: 2016
  end-page: 51
  ident: CR46
  article-title: Cytokine and chemokine profiles of aqueous humor and serum in horses with uveitis measured using multiplex bead immunoassay analysis
  publication-title: Vet. Immunol. Immunopathol.
  doi: 10.1016/j.vetimm.2016.09.008
– ident: CR32
– volume: 215
  start-page: 403
  year: 1990
  end-page: 410
  ident: CR36
  article-title: Basic local alignment search tool
  publication-title: J. Mol. Biol.
  doi: 10.1016/S0022-2836(05)80360-2
– volume: 15
  start-page: 145
  year: 2012
  end-page: 152
  ident: CR8
  article-title: Characterization of cytokines associated with Th17 cells in the eyes of horses with recurrent uveitis
  publication-title: Vet. Ophthalmol.
  doi: 10.1111/j.1463-5224.2011.00951.x
– year: 2013
  ident: CR37
  article-title: Regulation of interferon gamma signaling by suppressors of cytokine signaling and regulatory T cells
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2013.00469
– year: 2011
  ident: CR22
  article-title: Inhibition of SOCS1 −/− Lethal autoinflammatory disease correlated to enhanced peripheral Foxp3 + regulatory T cell homeostasis
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1003819
– volume: 2
  start-page: e24134
  year: 2013
  ident: CR38
  article-title: Therapeutic targeting of STAT pathways in CNS autoimmune diseases
  publication-title: JAK-STAT
  doi: 10.4161/jkst.24134
– volume: 35
  start-page: 515
  year: 1998
  end-page: 526
  ident: CR52
  article-title: Immunohistochemical studies in equine recurrent uveitis (ERU)
  publication-title: Vet. Pathol.
  doi: 10.1177/030098589803500606
– volume: 44
  start-page: D733
  year: 2016
  end-page: D745
  ident: CR26
  article-title: Reference sequence (RefSeq) database at NCBI: Current status, taxonomic expansion, and functional annotation
  publication-title: Nucl. Acids Res.
  doi: 10.1093/nar/gkv1189
– volume: 57
  start-page: 4504
  year: 2016
  ident: CR51
  article-title: Immunological characterization of intraocular lymphoid follicles in a spontaneous recurrent uveitis model
  publication-title: Investig. Ophthalmol. Vis. Sci.
  doi: 10.1167/iovs.16-19787
– volume: 84
  start-page: 299
  year: 2016
  end-page: 309
  ident: CR20
  article-title: Therapeutic potential for targeting the suppressor of cytokine signalling-1 pathway for the treatment of SLE
  publication-title: Scand. J. Immunol.
  doi: 10.1111/sji.12475
– year: 2016
  ident: CR49
  article-title: SOCS1 mimetic peptide suppresses chronic intraocular inflammatory disease (Uveitis)
  publication-title: Mediators Inflamm.
  doi: 10.1155/2016/2939370
– volume: 8
  start-page: e71619
  year: 2013
  ident: CR13
  article-title: A genome-wide association study identifies risk loci to equine recurrent uveitis in German warmblood horses
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0071619
– year: 2019
  ident: CR21
  article-title: Therapeutic implication of SOCS1 modulation in the treatment of autoimmunity and cancer
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2019.00324
– volume: 206
  start-page: 22
  year: 2015
  end-page: 29
  ident: CR47
  article-title: Equine recurrent uveitis: Human and equine perspectives
  publication-title: Vet. J.
  doi: 10.1016/j.tvjl.2015.06.017
– volume: 273
  start-page: 117
  year: 2014
  end-page: 119
  ident: CR19
  article-title: Quantitative analysis of the suppressors of cytokine signaling 1 and 3 in peripheral blood leukocytes of patients with multiple sclerosis
  publication-title: J. Neuroimmunol.
  doi: 10.1016/j.jneuroim.2014.05.013
– year: 2021
  ident: CR24
  article-title: Suppressor of cytokine signaling-1 mimetic peptides attenuate lymphocyte activation in the MRL/lpr mouse autoimmune model
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-021-86017-4
– volume: 16
  start-page: 10881
  year: 1988
  end-page: 10890
  ident: CR27
  article-title: Multiple sequence alignment with hierarchical clustering
  publication-title: Nucl. Acids Res.
  doi: 10.1093/nar/16.22.10881
– volume: 2013
  start-page: 986789
  year: 2013
  ident: CR50
  article-title: Th17 cells in immunity and autoimmunity
  publication-title: Clin. Dev. Immunol.
  doi: 10.1155/2013/986789
– year: 2021
  ident: CR1
  article-title: Immunological insights in equine recurrent uveitis
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2020.609855
– volume: 13
  start-page: 711
  year: 2007
  end-page: 718
  ident: CR12
  article-title: TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1
  publication-title: Nat. Med.
  doi: 10.1038/nm1585
– year: 2020
  ident: CR45
  article-title: Cytokine profiling in aqueous humor samples from patients with non-infectious uveitis associated with systemic inflammatory diseases
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2020.00358
– volume: 52
  start-page: 6978
  year: 2011
  ident: CR17
  article-title: Suppressor of cytokine signaling-1 (SOCS1) inhibits lymphocyte recruitment into the retina and protects SOCS1 transgenic rats and mice from ocular inflammation
  publication-title: Investig. Opthalmol. Vis. Sci.
  doi: 10.1167/iovs.11-7688
– year: 2008
  ident: CR31
  article-title: Phylogeny. fr: Robust phylogenetic analysis for the non-specialist
  publication-title: Nucl. Acids Res.
  doi: 10.1093/nar/gkn180
– volume: 243
  start-page: 170
  year: 1998
  end-page: 176
  ident: CR34
  article-title: Human IFNγ receptor cytoplasmic domain: Expression and interaction with HuIFNγ
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1006/bbrc.1998.8077
– volume: 47
  start-page: 396
  year: 2019
  end-page: 417
  ident: CR43
  article-title: New therapies in development for the management of non-infectious uveitis: A review
  publication-title: Clin. Exp. Ophthalmol.
  doi: 10.1111/ceo.13511
– volume: 20
  start-page: 633
  year: 2014
  end-page: 641
  ident: CR44
  article-title: Interleukin-35 induces regulatory B cells that suppress autoimmune disease
  publication-title: Nat. Med.
  doi: 10.1038/nm.3554
– volume: 42
  start-page: 57
  year: 2010
  end-page: 61
  ident: CR4
  article-title: Equine recurrent uveitis: The viewpoint from the USA
  publication-title: Equine Vet. J.
  doi: 10.1111/j.2042-3306.2010.tb05636.x
– volume: 45
  start-page: 177
  year: 2014
  end-page: 189
  ident: CR16
  article-title: Functional conservation of suppressors of cytokine signaling proteins between teleosts and mammals: Atlantic salmon SOCS1 binds to JAK/STAT family members and suppresses type I and II IFN signaling
  publication-title: Dev. Comp. Immunol.
  doi: 10.1016/j.dci.2014.02.009
– volume: 205
  start-page: 799
  year: 2008
  end-page: 810
  ident: CR11
  article-title: Either a Th17 or a Th1 effector response can drive autoimmunity: Conditions of disease induction affect dominant effector category
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20071258
– volume: 112
  start-page: 608
  year: 1994
  ident: CR6
  article-title: Calcific band keratopathy associated with the use of topical steroid-phosphate preparations
  publication-title: Arch. Ophthalmol.
  doi: 10.1001/archopht.1994.01090170052021
– ident: CR28
– volume: 111
  start-page: 491
  year: 2004
  end-page: 500
  ident: CR7
  article-title: Incidence and prevalence of uveitis in Northern California: The Northern California Epidemiology of Uveitis Study
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2003.06.014
– volume: 14
  start-page: 1188
  year: 2004
  end-page: 1190
  ident: CR30
  article-title: WebLogo: A sequence logo generator
  publication-title: Genome Res.
  doi: 10.1101/gr.849004
– volume: 45
  start-page: 177
  year: 2014
  ident: 11338_CR16
  publication-title: Dev. Comp. Immunol.
  doi: 10.1016/j.dci.2014.02.009
– volume: 4
  start-page: 139
  year: 1977
  ident: 11338_CR35
  publication-title: Mod. Adv. Toxicol.
– year: 2016
  ident: 11338_CR18
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M116.746164
– volume: 243
  start-page: 170
  year: 1998
  ident: 11338_CR34
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1006/bbrc.1998.8077
– volume: 47
  start-page: 396
  year: 2019
  ident: 11338_CR43
  publication-title: Clin. Exp. Ophthalmol.
  doi: 10.1111/ceo.13511
– year: 2015
  ident: 11338_CR14
  publication-title: Clin. Ophthalmol.
  doi: 10.2147/OPTH.S68595
– volume: 205
  start-page: 799
  year: 2008
  ident: 11338_CR11
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20071258
– volume: 112
  start-page: 608
  year: 1994
  ident: 11338_CR6
  publication-title: Arch. Ophthalmol.
  doi: 10.1001/archopht.1994.01090170052021
– year: 2021
  ident: 11338_CR24
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-021-86017-4
– year: 2020
  ident: 11338_CR45
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2020.00358
– year: 2016
  ident: 11338_CR49
  publication-title: Mediators Inflamm.
  doi: 10.1155/2016/2939370
– volume: 2016
  start-page: 1
  year: 2016
  ident: 11338_CR5
  publication-title: Mediators Inflamm.
– year: 2008
  ident: 11338_CR31
  publication-title: Nucl. Acids Res.
  doi: 10.1093/nar/gkn180
– volume: 20
  start-page: 633
  year: 2014
  ident: 11338_CR44
  publication-title: Nat. Med.
  doi: 10.1038/nm.3554
– year: 2015
  ident: 11338_CR42
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2015.00183
– volume: 273
  start-page: 117
  year: 2014
  ident: 11338_CR19
  publication-title: J. Neuroimmunol.
  doi: 10.1016/j.jneuroim.2014.05.013
– volume: 14
  start-page: 1188
  year: 2004
  ident: 11338_CR30
  publication-title: Genome Res.
  doi: 10.1101/gr.849004
– ident: 11338_CR28
  doi: 10.1007/978-1-0716-1036-7_18
– volume: 111
  start-page: 491
  year: 2004
  ident: 11338_CR7
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2003.06.014
– volume: 62
  start-page: 31
  year: 2015
  ident: 11338_CR25
  publication-title: J. Autoimmun.
  doi: 10.1016/j.jaut.2015.05.011
– volume: 206
  start-page: 22
  year: 2015
  ident: 11338_CR47
  publication-title: Vet. J.
  doi: 10.1016/j.tvjl.2015.06.017
– volume: 2013
  start-page: 986789
  year: 2013
  ident: 11338_CR50
  publication-title: Clin. Dev. Immunol.
  doi: 10.1155/2013/986789
– year: 2021
  ident: 11338_CR1
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2020.609855
– volume: 180
  start-page: 6070
  year: 2008
  ident: 11338_CR10
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.180.9.6070
– volume: 57
  start-page: 4504
  year: 2016
  ident: 11338_CR51
  publication-title: Investig. Ophthalmol. Vis. Sci.
  doi: 10.1167/iovs.16-19787
– volume: 23
  start-page: 160
  year: 2020
  ident: 11338_CR48
  publication-title: Vet. Ophthalmol.
  doi: 10.1111/vop.12704
– volume: 182
  start-page: 43
  year: 2016
  ident: 11338_CR46
  publication-title: Vet. Immunol. Immunopathol.
  doi: 10.1016/j.vetimm.2016.09.008
– volume: 8
  start-page: 557
  year: 1992
  ident: 11338_CR3
  publication-title: Vet. Clin. N. Am. Equine Pract.
  doi: 10.1016/S0749-0739(17)30441-8
– volume: 20
  start-page: 417
  year: 2004
  ident: 11338_CR2
  publication-title: Vet. Clin. N. Am. Equine Pract.
  doi: 10.1016/j.cveq.2004.04.010
– volume: 3
  start-page: 435
  year: 2003
  ident: 11338_CR15
  publication-title: Curr. Opin. Pharmacol.
  doi: 10.1016/S1471-4892(03)00070-5
– volume: 25
  start-page: 1189
  year: 2009
  ident: 11338_CR29
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btp033
– volume: 443
  start-page: 231
  year: 2012
  ident: 11338_CR41
  publication-title: Biochem. J.
  doi: 10.1042/BJ20111647
– volume: 8
  start-page: e71619
  year: 2013
  ident: 11338_CR13
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0071619
– volume: 2
  start-page: e24134
  year: 2013
  ident: 11338_CR38
  publication-title: JAK-STAT
  doi: 10.4161/jkst.24134
– ident: 11338_CR32
– year: 2019
  ident: 11338_CR21
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2019.00324
– volume: 232
  start-page: 108
  year: 2011
  ident: 11338_CR23
  publication-title: J. Neuroimmunol.
  doi: 10.1016/j.jneuroim.2010.10.018
– volume: 9
  start-page: 1558
  year: 2018
  ident: 11338_CR40
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-018-04013-1
– volume: 52
  start-page: 6978
  year: 2011
  ident: 11338_CR17
  publication-title: Investig. Opthalmol. Vis. Sci.
  doi: 10.1167/iovs.11-7688
– volume: 178
  start-page: 5058
  year: 2007
  ident: 11338_CR39
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.178.8.5058
– year: 2016
  ident: 11338_CR33
  publication-title: Curr. Protocols Bioinform.
  doi: 10.1002/cpbi.3
– volume: 35
  start-page: 515
  year: 1998
  ident: 11338_CR52
  publication-title: Vet. Pathol.
  doi: 10.1177/030098589803500606
– volume: 215
  start-page: 403
  year: 1990
  ident: 11338_CR36
  publication-title: J. Mol. Biol.
  doi: 10.1016/S0022-2836(05)80360-2
– volume: 84
  start-page: 299
  year: 2016
  ident: 11338_CR20
  publication-title: Scand. J. Immunol.
  doi: 10.1111/sji.12475
– volume: 42
  start-page: 57
  year: 2010
  ident: 11338_CR4
  publication-title: Equine Vet. J.
  doi: 10.1111/j.2042-3306.2010.tb05636.x
– volume: 15
  start-page: 145
  year: 2012
  ident: 11338_CR8
  publication-title: Vet. Ophthalmol.
  doi: 10.1111/j.1463-5224.2011.00951.x
– volume: 44
  start-page: D733
  year: 2016
  ident: 11338_CR26
  publication-title: Nucl. Acids Res.
  doi: 10.1093/nar/gkv1189
– volume: 71
  start-page: 17
  year: 1999
  ident: 11338_CR9
  publication-title: Vet. Immunol. Immunopathol.
  doi: 10.1016/S0165-2427(99)00082-3
– volume: 13
  start-page: 711
  year: 2007
  ident: 11338_CR12
  publication-title: Nat. Med.
  doi: 10.1038/nm1585
– year: 2013
  ident: 11338_CR37
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2013.00469
– volume: 16
  start-page: 10881
  year: 1988
  ident: 11338_CR27
  publication-title: Nucl. Acids Res.
  doi: 10.1093/nar/16.22.10881
– year: 2011
  ident: 11338_CR22
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1003819
SSID ssj0000529419
Score 2.4105616
Snippet Equine recurrent uveitis (ERU) is a painful and debilitating autoimmune disease and represents the only spontaneous model of human recurrent uveitis (RU)....
Abstract Equine recurrent uveitis (ERU) is a painful and debilitating autoimmune disease and represents the only spontaneous model of human recurrent uveitis...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 7177
SubjectTerms 631/250
631/250/127
631/250/24
631/250/249
631/250/251
631/250/2520
631/250/256
631/250/38
631/250/516
692/699/3161
692/699/3161/3177
Animals
Autoimmune Diseases
Bioinformatics
Blindness
Chronic Disease
Cytokines
Cytokines - metabolism
Horse Diseases - drug therapy
Horses
Humanities and Social Sciences
Inflammation
Janus kinase
Janus kinase 2
multidisciplinary
Patients
Peptides
Peptides - metabolism
Pilot Projects
Rodents
Science
Science (multidisciplinary)
SOCS-1 protein
Suppressor of Cytokine Signaling 1 Protein - metabolism
Suppressor of Cytokine Signaling Proteins - metabolism
Uveitis
Uveitis - drug therapy
Uveitis - veterinary
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9QwDI7QSkhcEMuzsKAgcYNq28R95AiI1QoJTqy0typJXTFiti0zLdr5Jft3sdPOsMPzwnUaV1Fs158n9mchXiSUNGRONXFj8iwGBzYmU8YYTWJT-iI2dcPNyR8-5qdn8P48O7826otrwiZ64OngjgmxeArRWVNqD8Ypq1SRgNOJqhVnWPz1pTB2LZmaWL2VgdTMXTKJLo_XFKm4m4xyr5TzsvhyLxIFwv7focxfiyV_ujENgejkjrg9I0j5etr5obiB7V1xc5opubknrrhERJJucSnXtsFhI21bS2SqCOs3sl8su0EOnQzEsvJiMZFsdK3sGolfR0KdcsV_wjNtkxy_IZMeyXmcD8n1rFW5HvtQQdutWMxvhu4LC3I1iOUG9zilN19wg6TsuW6mxvvi7OTdp7en8Tx9IfaE4oYYNYDX7KEuLyDRUINSiVfgEUB5ZwwStnGZL703WQ2obKELp01SWp1q0A_EQdu1-EjIvEBEaFyS2RoIcNocXIr0ZusdFsZEIt1qovIzNTlPyFhW4Ypcl9WkvYq0VwXtVZeReLmT6Sdijr-ufsMK3q1kUu3wA5laNZta9S9Ti8TR1jyq2dPXlSIIZwjzmCISz3ePyUf54sW22I1hDSWKqswhEg8na9rtRHOKSDgwEsWene1tdf9Ju_gceMANiaVAkq-2FvljW38-isf_4yieiFuKXYkrP_WROBhWIz4ldDa4Z8ERvwMO3jWR
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lj9QwDI5gERIXxHsLCwoSN6i2TdxHTggQqxUSnFhpblWSujBitu3OdNDOL-HvYqedWQ2PvU7jKlPbsR3bn4V4lVDQkDnVxI3Jsxgc2JhEGWM0iU3pRGzqhpuTP3_JT8_g0yybTRduq6mscnsmhoO67jzfkR8rMpWGbIsp3vYXMU-N4uzqNELjpriVkqvCUl3Mit0dC2exIDVTr0yiy-MV2SvuKaMILOXoLL7cs0cBtv9fvubfJZN_5E2DOTq5J-5OfqR8NzL-vriB7QNxe5wsuXkofnGhiCQO40KubIPDRtq2lsiAEdZvZD9fdIMcOhngZeX5fITa6FrZNRIv1uR7yiVfxTN4k1z_RIY-ktNQH6Lrmbdyte5DHW23ZDK_GbofTMg1IZbb3OOU3nzObZKy5-qZGh-Js5OPXz-cxtMMhtiTLzfEqAG8Zj11eQGJhhqUSrwCjwDKO2OQPByX-dJ7k9WAyha6cNokpdWpBv1YHLRdi4dC5gUiQuOSzNZAbqfNwaVIb7beYWFMJNItJyo_AZTznIxFFRLluqxG7lXEvSpwr7qMxOsdTT_Cc1y7-j0zeLeSobXDD93yWzVpKq3NPPmEWVNqD8Ypq1SRgNOJqhWH9JE42opHNen7qrqSzki83D0mTeX0i22xW4c1FC6qModIPBmlabcTzYEieYORKPbkbG-r-0_a-feABm6ILAWifLOVyKtt_f9TPL3-XzwTdxQrCVd26iNxMCzX-Jy8r8G9CCr2G5s5Lzg
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Li9RAEG6WFcGL-Da6SgveNJp0Vx59EFFxWYT15MDeQnenosPOJrMziez8Ev-uVXmMjI6C16QqNKmq9Ffpqq-EeB5R0pA4VYWVSZMQHNiQXBlDNJGN6YtYlRU3J59-Tk9m8OksOTsQ07ij8QWu96Z2PE9qtlq8urrcvKWAfzO0jOev17QJcaMYpVUxp1whYcprtDMp9vLTEe4PXN_KQGzG3pn9qjv7U0_jvw97_llC-ds5ar89Hd8SN0dcKd8NjnBbHGB9R1wfJk1u7oofXDgiyeK4kGtbYbuRti4lMoGE9Ru5nC-aVraN7Olm5cV8oN5oatlUEi87wqJyxb_mmcxJdt-RqZDkOOSH9JZsa7nuln1dbbNiNb9pm3NW5BoRy23vYUxPvuC2SbnkapoS74nZ8ccvH07CcSZD6AnbtSFqAK85bl2aQaShBKUir8AjgPLOGCTE4xKfe2-SElDZTGdOmyi3Otag74vDuqnxoZBphohQuSixJRAMtSm4GOnJ1jvMjAlEPFmi8CNhOc_NWBT9wbnOi8F6BVmv6K1XXAXixVZnOdB1_FP6PRt4K8lU2_2FZvW1GCOXZBNPGDGpcu3BOGWVyiJwOlKl4hQ_EEeTexST-xaKgJ0hJGSyQDzb3qbI5eMYW2PT9TKUPqo8hUA8GLxpuxLNiSOhw0BkO362s9TdO_X8W88ObkgtBtJ8OXnkr2X9_VU8-j_xx-KG4qDhyk99JA7bVYdPCJ217mkfcj8BVEM3AQ
  priority: 102
  providerName: Scholars Portal
Title Open label safety and efficacy pilot to study mitigation of equine recurrent uveitis through topical suppressor of cytokine signaling-1 mimetic peptide
URI https://link.springer.com/article/10.1038/s41598-022-11338-x
https://www.ncbi.nlm.nih.gov/pubmed/35505065
https://www.proquest.com/docview/2658985397
https://www.proquest.com/docview/2659602864
https://pubmed.ncbi.nlm.nih.gov/PMC9065145
https://doaj.org/article/115c6235f83c49b2a22704b302d20713
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVFSB
  databaseName: Free Full-Text Journals in Chemistry
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: HH5
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: http://abc-chemistry.org/
  providerName: ABC ChemistRy
– providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: KQ8
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: DOA
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVEBS
  databaseName: EBSCOhost Academic Search Ultimate
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: ABDBF
  dateStart: 20121221
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  providerName: EBSCOhost
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: DIK
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: GX1
  dateStart: 0
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: M~E
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: RPM
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVAQT
  databaseName: Springer Nature - nature.com Journals - Fully Open Access
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: NAO
  dateStart: 20111201
  isFulltext: true
  titleUrlDefault: https://www.nature.com/siteindex/index.html
  providerName: Nature Publishing
– providerCode: PRVPQU
  databaseName: Health & Medical Collection (ProQuest)
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: 7X7
  dateStart: 20210101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central - New (Subscription)
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: BENPR
  dateStart: 20210101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVFZP
  databaseName: Scholars Portal Journals: Open Access
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 20250131
  omitProxy: true
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: M48
  dateStart: 20110801
  isFulltext: true
  titleUrlDefault: http://journals.scholarsportal.info
  providerName: Scholars Portal
– providerCode: PRVAVX
  databaseName: Springer Nature HAS Fully OA
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: AAJSJ
  dateStart: 20111201
  isFulltext: true
  titleUrlDefault: https://www.springernature.com
  providerName: Springer Nature
– providerCode: PRVAVX
  databaseName: Springer Nature OA Free Journals
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: C6C
  dateStart: 20111201
  isFulltext: true
  titleUrlDefault: http://www.springeropen.com/
  providerName: Springer Nature
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3fb9MwELbGJh4RvwkalZF4g4jEvsTxY1dtmiptQsCkvkW248BEl5Q2RfQv4d_lzkmLCgOJl1ZK7iIrdxd_Z999ZuxVgklDZkUd1zrPYrBgYnRlH3udmBS_iHVVU3PyxWV-fgXTWTY7YGLbCxOK9gOlZfhMb6vD3q5woqFmMEydUkqrYsSNR4WSAoPxaDyefpjuVlZo7wpSPXTIJLK4RXlvFgpk_bchzD8LJX_bLQ2T0Nl9dm9Aj3zcj_cBO_DNQ3a3P09y84j9oPIQjnb1c74yte823DQV90QTYdyGL67nbce7lgdSWX5z3RNstA1va-6_rhFx8iUtwBNlE19_80R4xIejfFBvQRblq_UiVM-2S1Jzm679QopUCWKouT1O8ck31BzJF1QzU_nH7Ors9OPkPB5OXogdIrgu9hLASYpOmytIJFQgROIEOA8gnNXaI66xmSuc01kFXhgllZU6KYxMJcgn7LBpG_-M8Vx576G2SWYqQLBpcrCpxycbZ73SOmLp1hKlG2jJ6XSMeRm2x2VR9tYr0XplsF75PWKvdzqLnpTjn9InZOCdJBFqhwvt8lM5OBjKZg6RYFYX0oG2wgihErAyEZWgRD5ix1v3KIcoX5UC4ZtGvKNVxF7ubmN80qaLaXy7DjKYJIoih4g97b1pNxJJ6SFiwIipPT_bG-r-neb6c-AA16iWAmq-2Xrkr2H9_VU8_z_xY3bYLdf-BcKuzo7YHTVToyHa8P_k9PLde7w6ySejsJSBvxdQ_AQAGDHW
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Jb9QwFLZKEYILYi2BAkaCE0RN7JfFB4TYqildTq3UW7AdB0ZMk3QmA51fwr_gN_JelqmGpbdeEz_Lyfv8FvstjD0P0GmIjCj8QsWRDwa0j1B2vlOBDlEiFnlBycn7B_HoCD4dR8dr7NeQC0NhlYNMbAV1Xlk6I98SqCoV6haVvKlPfeoaRberQwuNDha7bvEDXbbZ650PyN8XQmx_PHw_8vuuAr5F66TxnQSwkpBn4gQCCTkIEVgB1gEIa5RyqLNNZFNrVZSDEzqRiZEqSLUMJUic9wq7CjIAqtWfHCfLMx26NYNQ9bk5gUy3ZqgfKYcNPb6QvEH_bEX_tW0C_mXb_h2i-cc9bav-tm-xm73dyt92QLvN1lx5h13rOlku7rKfFJjCEVFuwme6cM2C6zLnjgpUaLvg9XhSNbypeFvOlp-Mu9IeVcmrgrvTOdq6fEpH_1Qsis-_Oyq1xPsmQkhXE5b4bF63cbvVlMjsoqm-ESHFoGhKq_dDnPmE0jJ5TdE6ubvHji6FO_fZelmV7gHjceKcg8IEkc4BzVwdgwkdzqytcYlSHgsHTmS2L4hOfTkmWXsxL9Os416G3Mta7mVnHnu5pKm7ciAXjn5HDF6OpFLe7YNq-iXrJQOOjSzaoFGRSgvKCC1EEoCRgcgFHSF4bHOAR9bLl1l2vhs89mz5GiUDXffo0lXzdgy6pyKNwWMbHZqWK5HkmKL16bFkBWcrS119U46_ttXHFZKFgJSvBkSeL-v_v-LhxV_xlF0fHe7vZXs7B7uP2A1BG4aiSuUmW2-mc_cYLb_GPGm3G2efL3t__wblCmny
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLbGEIgXxJ3AACPBE0RNbCeOHxACRrUxmHhg0t6C7ThQ0SVZm8L6S_gv_DrOcZJO5bK3vVWNj5X2fD4XnxshTyJwGhLDyrBUaRIKI3QIUHahU5GOQSKWRYnFyR_2050D8e4wOdwgv4ZaGEyrHGSiF9RFbfGOfMRAVSrQLUqOyj4t4uP2-GVzHOIEKYy0DuM0OojsueUPcN_mL3a3gddPGRu__fRmJ-wnDIQWLJU2dFwIyxGFJpUi4qIQjEWWCeuEYNYo5UB_m8Rm1qqkEI5pyaXhKso0j7ngsO8FclHCJ0wnk4dydb-DETQRq75OJ-LZaA66EuvZwPuL0TMMT9Z0oR8Z8C879-90zT9itl4Vjq-Rq70NS191oLtONlx1g1zqploub5KfmKRCAV1uSue6dO2S6qqgDptVaLukzWRat7StqW9tS48mXZuPuqJ1Sd3xAuxeOsMwADaOoovvDtsu0X6gENA1iCs6XzQ-h7eeIZldtvU3JMR8FI0l9mEMOx9hiSZtMHOncLfIwblw5zbZrOrK3SU0lc45UZoo0YUAk1enwsQOdtbWOKlUQOKBE7ntm6PjjI5p7oP0PMs77uXAvdxzLz8JyLMVTdO1Bjlz9Wtk8GoltvX2X9SzL3kvJWBtYsEeTcqMW6EM04zJSBgesYLhdUJAtgZ45L2smeenJyMgj1ePQUpg6EdXrl74NeCqsiwVAbnToWn1JhydVLBEAyLXcLb2qutPqslX34lcAVksgPL5gMjT1_r_X3Hv7F_xiFyGk52_393fu0-uMMwh8gmXW2SznS3cAzACW_PQnzZKPp_38f4N88tuLQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Open+label+safety+and+efficacy+pilot+to+study+mitigation+of+equine+recurrent+uveitis+through+topical+suppressor+of+cytokine+signaling-1+mimetic+peptide&rft.jtitle=Scientific+reports&rft.au=Plummer%2C+Caryn+E.&rft.au=Polk%2C+Timothy&rft.au=Sharma%2C+Jatin&rft.au=Bae%2C+Sanghyo+Sarah&rft.date=2022-05-03&rft.pub=Nature+Publishing+Group+UK&rft.eissn=2045-2322&rft.volume=12&rft.issue=1&rft_id=info:doi/10.1038%2Fs41598-022-11338-x&rft.externalDocID=10_1038_s41598_022_11338_x
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon